Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

First published online October 26, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0268v1
25/2/364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Li, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Li, G.
Submitted on May 2, 2006
Accepted on October 20, 2006

Tissue-Specific Stem Cells

Chondrogenic-differentiation Alters the Immunosuppressive Property of Bone Marrow-derived Mesenchymal Stem Cells and the Effect Is Partially Due to the Up-regulated Expression of B7 Molecules

Xi Chen 1, Angela McClurg 2, Guang-Qian Zhou 3, Mervyn McCaigue 1, Marilyn Ann Armstrong 2, Gang Li 1*

1 Department of Orthopaedic Surgery, Center for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom
2 Department of Immunology, Center for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom
3 Department of Surgery, Center for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom

* To whom correspondence should be addressed. E-mail: g.li{at}qub.ac.uk.


  Abstract

To investigate the immunosuppressive properties of mesenchymal stem cells (MSCs), in the present study we examined the immunogenicity of undifferentiated and tri-lineage (chondrocytes, osteoblasts and adipocytes) differentiated rat bone marrow-derived MSCs under xenogeneic conditions. After chondrogenic-differentiation, rat bone marrow-derived MSCs stimulated human peripheral blood monocyte-derived DCs (hDCs), leading to 8- and 4-fold higher lymphocyte proliferation and cytotoxicity than that of undifferentiated MSCs. The Chondrogenic-differentiated MSCs were chemotactic to hDCs in Dunn chamber chemotaxis system and were rosetted by hDCs inrosette assays. Flow cytometry analysis revealed that chondrogenic-differentiated MSCs had promoted hDCs maturation causing higher CD83 expression in hDCs, whereas undifferentiated MSCs, osteogenic-and adipogenic-differentiated MSCs showed inhibitory effect on hDCs maturation. The co-stimulatory molecules B7 were up-regulated only in the chondrogenic-differentiated MSCs. After blocking B7 molecules with specific monoclonal antibodies in the chondrogenic-differentiated MSCs, CD83 expression of co-cultured hDCs was greatly reduced. In conclusion, chondrogenic differentiation may increase the immunogenicity of MSCs, leading to stimulation of DCs. The up-regulated expression of B7 molecules on the chondrogenic differentiated MSCs may be partially responsible for this event.

Key Words. MSCs, immunogenicity, chondrogenic-differentiation, DCs




This article has been cited by other articles:


Home page
 Stem CellsHome page
M. L. Weiss, C. Anderson, S. Medicetty, K. B. Seshareddy, R. J. Weiss, I. VanderWerff, D. Troyer, and K. R. McIntosh
Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells
Stem Cells, November 1, 2008; 26(11): 2865 - 2874.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.